IL145580A0 - A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate - Google Patents

A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate

Info

Publication number: IL145580A0
Authority: IL; Israel
Prior art keywords: amoxycillin; pharmaceutical composition; modified release; release pharmaceutical; potassium clavulanate
Prior art date: 1999-04-13

Application number

IL14558000A

Other languages

English (en)

Original Assignee

Beecham Pharm Pte Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2000-04-11

Publication date

2002-11-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27383840&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL145580(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-11 Application filed by Beecham Pharm Pte Ltd filed Critical Beecham Pharm Pte Ltd

2002-11-10 Publication of IL145580A0 publication Critical patent/IL145580A0/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

IL14558000A 1999-04-13 2000-04-11 A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate IL145580A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US12907499P	1999-04-13	1999-04-13
US15072799P	1999-08-25	1999-08-25
US15981399P	1999-10-15	1999-10-15
PCT/IB2000/000992 WO2000061116A2 (fr)	1999-04-13	2000-04-11	Nouveau procede de traitement

Publications (1)

Publication Number	Publication Date
IL145580A0 true IL145580A0 (en)	2002-11-10

Family

ID=27383840

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14558000A IL145580A0 (en)	1999-04-13	2000-04-11	A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
IL145580A IL145580A (en)	1999-04-13	2001-09-24	Use of amoxicillin and potassium clavulanate in the manufacture of a medicament for treating bacterial infections and modified release pharmaceutical composition comprising them

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL145580A IL145580A (en)	1999-04-13	2001-09-24	Use of amoxicillin and potassium clavulanate in the manufacture of a medicament for treating bacterial infections and modified release pharmaceutical composition comprising them

Country Status (44)

Country	Link
EP (4)	EP1044680B1 (fr)
JP (2)	JP4880125B2 (fr)
KR (1)	KR100634937B1 (fr)
CN (1)	CN100382782C (fr)
AP (1)	AP1806A (fr)
AR (1)	AR031068A1 (fr)
AT (2)	ATE242629T1 (fr)
AU (1)	AU767177B2 (fr)
BE (2)	BE1013309A5 (fr)
BG (1)	BG65006B1 (fr)
BR (1)	BRPI0009719B8 (fr)
CA (1)	CA2366304C (fr)
CO (1)	CO5170471A1 (fr)
CZ (1)	CZ298801B6 (fr)
DE (3)	DE10017883A1 (fr)
DK (3)	DK200000602A (fr)
DZ (1)	DZ3150A1 (fr)
EA (1)	EA004310B1 (fr)
ES (2)	ES2190692B1 (fr)
FI (2)	FI4823U1 (fr)
FR (1)	FR2792198A1 (fr)
GB (1)	GB2351661B (fr)
GR (1)	GR1003560B (fr)
HU (1)	HU229097B1 (fr)
IE (1)	IE20000271A1 (fr)
IL (2)	IL145580A0 (fr)
IT (1)	ITMI20000788A1 (fr)
MA (1)	MA25352A1 (fr)
MX (1)	MXPA01010377A (fr)
MY (1)	MY119953A (fr)
NL (2)	NL1014915C2 (fr)
NO (1)	NO329694B1 (fr)
NZ (1)	NZ514575A (fr)
OA (1)	OA11926A (fr)
PE (1)	PE20010053A1 (fr)
PL (1)	PL197448B1 (fr)
PT (2)	PT1044680E (fr)
RO (1)	RO120817B1 (fr)
SE (1)	SE0001330L (fr)
SI (2)	SI1044680T1 (fr)
SK (1)	SK285140B6 (fr)
TR (1)	TR200102963T2 (fr)
TW (1)	TWI235067B (fr)
WO (1)	WO2000061116A2 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9407386D0 (en)	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
TR199800415T1 (en)	1995-09-07	1998-05-21	Smithkline Beecham Corporation	Farmas�tik form�lasyon.
SE9802973D0 (sv)	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en)	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20030035839A1 (en) *	2001-05-15	2003-02-20	Peirce Management, Llc	Pharmaceutical composition for both intraoral and oral administration
CN1610551A (zh)	2001-07-06	2005-04-27	恩德制药公司	用作止痛剂的6－羟基羟吗啡酮的肠胃外给药
GB0117618D0 (en) *	2001-07-19	2001-09-12	Phoqus Ltd	Pharmaceutical dosage form
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
CA2480826C (fr)	2002-04-09	2012-02-07	Flamel Technologies	Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
JP2005528383A (ja) *	2002-04-10	2005-09-22	ミラー，フレッド，エイチ．	多重相・複数コンパートメントカプセルシステム
US20050042289A1 (en) *	2003-04-29	2005-02-24	Yamanouchi Pharma Technologies, Inc.	Tablets and methods for modified release of hydrophylic and other active agents
JP2007502294A (ja)	2003-08-12	2007-02-08	アドバンシスファーマスーティカルコーポレイション	抗生物質製剤、その使用法及び作成方法
EP1541129A1 (fr) *	2003-12-12	2005-06-15	Cimex AG	Composition effervescente pharmaceutique contenant de l'amoxicilline et du clavulanate
EP1750717B1 (fr) *	2004-02-11	2017-07-19	Rubicon Research Private Limited	Compositions pharmaceutiques a liberation controlee presentant une meilleure biodisponibilite
WO2005099672A1 (fr) *	2004-04-13	2005-10-27	Ranbaxy Laboratories Limited	Formulation pharmaceutique a liberation modifiee contenant de l'amoxicilline et du clavulanate
EP1880716A1 (fr) *	2006-07-19	2008-01-23	Sandoz AG	Kit comprenant un produit actif métastable à l'acide et un produit actif stable à l'acide
WO2008045060A1 (fr) *	2006-10-10	2008-04-17	Penwest Pharmaceuticals Co.	Formulations robustes à libération prolongée
TR200909787A2 (tr)	2009-12-25	2011-07-21	Bi̇lgi̇ç Mahmut	Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
TR201000686A1 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
TR201000687A1 (tr)	2010-01-29	2011-08-22	Bi̇lgi̇ç Mahmut	Aktif madde olarak sefiksim ve klavulanik asit içeren efervesan formülasyonlar
WO2016164470A1 (fr)	2015-04-07	2016-10-13	Church & Dwight Co., Inc.	Compositions gommeuses à plusieurs composants avec un cœur mou
CN109394718B (zh) *	2018-11-15	2021-04-27	石药集团中诺药业（石家庄）有限公司	一种阿莫西林分散片及其制备方法
CN110051637A (zh) *	2019-05-21	2019-07-26	葵花药业集团北京药物研究院有限公司	阿莫西林克拉维酸钾制剂及其制备方法
WO2023208241A1 (fr) *	2022-04-29	2023-11-02	越洋医药开发(广州)有限公司	Préparation solide orale à libération prolongée de pirfénidone

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0008905B1 (fr) *	1978-09-06	1983-02-16	Beecham Group Plc	Compositions pharmaceutiques contenant deux dérivés de bêta-lactame
IL58461A0 (en) *	1978-10-27	1980-01-31	Beecham Group Ltd	Intramammary compositions comprising a clavulanic acid salt
FR2470599A1 (fr) *	1979-12-07	1981-06-12	Panoz Donald	Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
GB9007945D0 (en) *	1990-04-07	1990-06-06	Beecham Group Plc	Pharmaceutical formulation
GB9109862D0 (en) *	1991-05-08	1991-07-03	Beecham Lab Sa	Pharmaceutical formulations
IT1255522B (it) *	1992-09-24	1995-11-09	Ubaldo Conte	Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
EP1034784A3 (fr) *	1993-01-22	2001-06-27	Smithkline Beecham Plc	Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien
GB9311030D0 (en) *	1993-05-28	1993-07-14	Smithkline Beecham Corp	Pharmaceutical formulations
IL109770A0 (en) *	1993-05-29	1994-11-28	Smithkline Beecham Corp	Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
GB9407386D0 (en) *	1994-04-14	1994-06-08	Smithkline Beecham Plc	Pharmaceutical formulation
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
ITMI941169A1 (it) *	1994-06-06	1995-12-06	Smithkline Beecham Farma	Formulazioni farmaceutiche
GB9416600D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
GB9416599D0 (en) *	1994-08-17	1994-10-12	Smithkline Beecham Plc	Pharmaceutical formulation
TR199800415T1 (en) *	1995-09-07	1998-05-21	Smithkline Beecham Corporation	Farmas�tik form�lasyon.
GB9616536D0 (en) *	1996-08-06	1996-09-25	Quadrant Holdings Cambridge	Co-amoxiclav dosage form
CA2280857A1 (fr) *	1997-02-14	1998-08-20	Smithkline Beecham Laboratoires Pharmaceutiques	Formulations pharmaceutiques comprenant de l'amoxycilline et du clavulanate
EE9900396A (et) *	1997-03-11	2000-04-17	Almag Al	Meetod ning seade metallide katmiseks
SE9700885D0 (sv) *	1997-03-12	1997-03-12	Astra Ab	New pharmaceutical formulation
ID22340A (id) *	1997-03-25	1999-09-30	Takeda Chemical Industries Ltd	Komposisi farmasi lekat-mukosa saluran pencernaan
JP3746901B2 (ja) *	1997-10-15	2006-02-22	ユニ・チャーム株式会社	開閉自在容器
GB9815532D0 (en) *	1998-07-17	1998-09-16	Lek Pharmaceutical & Cvhemical	Pharmaceutical suspension formulation
GB9818927D0 (en) *	1998-08-28	1998-10-21	Smithkline Beecham Plc	Pharmaceutical formulation
US6225304B1 (en) *	1999-02-17	2001-05-01	Pharmaceutical Solutions, Inc.	Soluble forms of amoxicillin and treatment of animals

2000
- 2000-04-11 NO NO20001870A patent/NO329694B1/no not_active IP Right Cessation
- 2000-04-11 EP EP00303033A patent/EP1044680B1/fr not_active Expired - Lifetime
- 2000-04-11 EP EP02078926A patent/EP1269996A1/fr not_active Withdrawn
- 2000-04-11 PT PT00303033T patent/PT1044680E/pt unknown
- 2000-04-11 AT AT00303033T patent/ATE242629T1/de active
- 2000-04-11 AT AT0027900U patent/AT4327U1/de not_active IP Right Cessation
- 2000-04-11 BE BE2000/0255A patent/BE1013309A5/fr not_active IP Right Cessation
- 2000-04-11 FI FI20000164U patent/FI4823U1/fi active
- 2000-04-11 CZ CZ20001311A patent/CZ298801B6/cs not_active IP Right Cessation
- 2000-04-11 CN CNB008086737A patent/CN100382782C/zh not_active Expired - Lifetime
- 2000-04-11 AP APAP/P/2001/002284A patent/AP1806A/en active
- 2000-04-11 DK DK200000602A patent/DK200000602A/da not_active Application Discontinuation
- 2000-04-11 IT IT2000MI000788A patent/ITMI20000788A1/it unknown
- 2000-04-11 IE IE20000271A patent/IE20000271A1/en not_active IP Right Cessation
- 2000-04-11 TW TW089106937A patent/TWI235067B/zh not_active IP Right Cessation
- 2000-04-11 ES ES200000935A patent/ES2190692B1/es not_active Withdrawn - After Issue
- 2000-04-11 CO CO00026419A patent/CO5170471A1/es not_active Application Discontinuation
- 2000-04-11 NL NL1014915A patent/NL1014915C2/nl not_active IP Right Cessation
- 2000-04-11 DK DK00303033T patent/DK1044680T3/da active
- 2000-04-11 EA EA200101075A patent/EA004310B1/ru not_active IP Right Cessation
- 2000-04-11 SE SE0001330A patent/SE0001330L/xx not_active Application Discontinuation
- 2000-04-11 OA OA1200100257A patent/OA11926A/en unknown
- 2000-04-11 ES ES00303033T patent/ES2202004T3/es not_active Expired - Lifetime
- 2000-04-11 MX MXPA01010377A patent/MXPA01010377A/es active IP Right Grant
- 2000-04-11 CA CA002366304A patent/CA2366304C/fr not_active Expired - Lifetime
- 2000-04-11 SI SI200030183T patent/SI1044680T1/xx unknown
- 2000-04-11 FI FI20000863A patent/FI20000863A7/fi unknown
- 2000-04-11 HU HU0001471A patent/HU229097B1/hu unknown
- 2000-04-11 PT PT102450A patent/PT102450B/pt active IP Right Grant
- 2000-04-11 AR ARP000101657A patent/AR031068A1/es not_active Application Discontinuation
- 2000-04-11 SI SI200000097A patent/SI20304A/sl not_active IP Right Cessation
- 2000-04-11 BR BRPI0009719A patent/BRPI0009719B8/pt not_active IP Right Cessation
- 2000-04-11 NL NL1014914A patent/NL1014914C1/nl not_active IP Right Cessation
- 2000-04-11 MY MYPI20001509A patent/MY119953A/en unknown
- 2000-04-11 GB GB0008923A patent/GB2351661B/en not_active Revoked
- 2000-04-11 RO ROA200000399A patent/RO120817B1/ro unknown
- 2000-04-11 SK SK534-2000A patent/SK285140B6/sk not_active IP Right Cessation
- 2000-04-11 FR FR0004631A patent/FR2792198A1/fr active Pending
- 2000-04-11 DE DE10017883A patent/DE10017883A1/de not_active Withdrawn
- 2000-04-11 EP EP02078928A patent/EP1269997A1/fr not_active Withdrawn
- 2000-04-11 DE DE60003255T patent/DE60003255T2/de not_active Expired - Lifetime
- 2000-04-11 EP EP02078927A patent/EP1270005A3/fr not_active Withdrawn
- 2000-04-11 DZ DZ003150A patent/DZ3150A1/fr active
- 2000-04-11 BE BE00/0256A patent/BE1012733A6/fr not_active IP Right Cessation
- 2000-04-11 DK DK200000133U patent/DK200000133U3/da not_active IP Right Cessation
- 2000-04-11 DE DE20006626U patent/DE20006626U1/de not_active Expired - Lifetime
- 2000-04-11 JP JP2000610449A patent/JP4880125B2/ja not_active Expired - Lifetime
- 2000-04-11 BG BG104329A patent/BG65006B1/bg unknown
- 2000-04-11 NZ NZ514575A patent/NZ514575A/en not_active IP Right Cessation
- 2000-04-11 IL IL14558000A patent/IL145580A0/xx active IP Right Grant
- 2000-04-11 PL PL339591A patent/PL197448B1/pl unknown
- 2000-04-11 WO PCT/IB2000/000992 patent/WO2000061116A2/fr not_active Ceased
- 2000-04-11 PE PE2000000332A patent/PE20010053A1/es not_active Application Discontinuation
- 2000-04-11 GR GR20000100122A patent/GR1003560B/el unknown
- 2000-04-11 KR KR1020017012988A patent/KR100634937B1/ko not_active Expired - Fee Related
- 2000-04-11 AU AU57020/00A patent/AU767177B2/en not_active Expired
- 2000-04-11 TR TR2001/02963T patent/TR200102963T2/xx unknown
2001
- 2001-09-24 IL IL145580A patent/IL145580A/en not_active IP Right Cessation
- 2001-10-12 MA MA26356A patent/MA25352A1/fr unknown
2011
- 2011-07-22 JP JP2011161132A patent/JP2011256180A/ja active Pending

Also Published As

Publication number	Publication date
AU767177B2 (en)	2003-11-06
CN1382040A (zh)	2002-11-27
GR1003560B (el)	2001-03-16
AP2001002284A0 (en)	2001-12-31
CO5170471A1 (es)	2002-06-27
NL1014915C2 (nl)	2001-02-12
GB2351661A (en)	2001-01-10
DK200000133U3 (da)	2000-07-28
DE60003255D1 (de)	2003-07-17
PT102450A (pt)	2001-02-01
WO2000061116A3 (fr)	2001-02-01
SE0001330L (sv)	2000-10-14
PL197448B1 (pl)	2008-03-31
SK285140B6 (sk)	2006-07-07
NO20001870L (no)	2000-10-16
CZ20001311A3 (cs)	2000-11-15
IL145580A (en)	2007-05-15
PL339591A1 (en)	2000-10-23
WO2000061116A2 (fr)	2000-10-19
CN100382782C (zh)	2008-04-23
DZ3150A1 (fr)	2000-10-19
EP1270005A3 (fr)	2006-05-17
ES2190692B1 (es)	2004-11-16
GB2351661B (en)	2001-10-10
EA200101075A1 (ru)	2002-04-25
MY119953A (en)	2005-08-30
KR20020015312A (ko)	2002-02-27
BE1013309A5 (fr)	2001-11-06
ITMI20000788A1 (it)	2001-10-11
FI20000863A0 (fi)	2000-04-11
DE20006626U1 (de)	2000-10-19
MA25352A1 (fr)	2001-12-31
KR100634937B1 (ko)	2006-10-17
FIU20000164U0 (fi)	2000-04-11
HK1032741A1 (en)	2001-08-03
FI20000863L (fi)	2000-10-13
CA2366304A1 (fr)	2000-10-19
TR200102963T2 (tr)	2002-02-21
NO329694B1 (no)	2010-12-06
EA004310B1 (ru)	2004-02-26
EP1269997A1 (fr)	2003-01-02
HU229097B1 (en)	2013-07-29
ATE242629T1 (de)	2003-06-15
HU0001471D0 (en)	2000-06-28
FI20000863A7 (fi)	2000-10-13
GB0008923D0 (en)	2000-05-31
BG104329A (en)	2001-11-30
OA11926A (en)	2006-04-12
AU5702000A (en)	2000-11-14
BG65006B1 (bg)	2006-12-29
IE20000271A1 (en)	2001-04-04
HUP0001471A3 (en)	2001-10-29
JP4880125B2 (ja)	2012-02-22
PT1044680E (pt)	2003-10-31
HUP0001471A2 (en)	2001-03-28
SE0001330D0 (sv)	2000-04-11
NZ514575A (en)	2004-05-28
AP1806A (en)	2007-12-14
DE10017883A1 (de)	2000-10-26
SI20304A (sl)	2001-02-28
JP2002541187A (ja)	2002-12-03
AT4327U1 (de)	2001-06-25
PT102450B (pt)	2003-09-30
PE20010053A1 (es)	2001-03-10
ES2202004T3 (es)	2004-04-01
BR0009719B1 (pt)	2014-09-30
JP2011256180A (ja)	2011-12-22
CZ298801B6 (cs)	2008-02-06
SI1044680T1 (en)	2003-12-31
CA2366304C (fr)	2004-06-29
FR2792198A1 (fr)	2000-10-20
BR0009719A (pt)	2002-01-08
NL1014914C1 (nl)	2000-10-16
ES2190692A1 (es)	2003-08-01
DK1044680T3 (da)	2003-09-29
RO120817B1 (ro)	2006-08-30
BRPI0009719B8 (pt)	2021-05-25
ITMI20000788A0 (it)	2000-04-11
BE1012733A6 (fr)	2001-02-06
DK200000602A (da)	2000-10-14
EP1269996A1 (fr)	2003-01-02
DE60003255T2 (de)	2004-05-06
NO20001870D0 (no)	2000-04-11
MXPA01010377A (es)	2002-10-23
FI4823U1 (fi)	2001-02-16
AR031068A1 (es)	2003-09-10
EP1044680A1 (fr)	2000-10-18
TWI235067B (en)	2005-07-01
EP1044680B1 (fr)	2003-06-11
EP1270005A2 (fr)	2003-01-02
SK5342000A3 (en)	2000-11-07
NL1014915A1 (nl)	2000-10-16

Legal Events

Date	Code	Title	Description
2007-10-31	FF	Patent granted
2007-10-31	KB	Patent renewed

Publication	Publication Date	Title
IL145580A0 (en)	2002-11-10	A modified release pharmaceutical composition comprising amoxycillin and potassium clavulanate
IL145581A0 (en)	2002-11-10	A modified release pharmaceutical composition comprising amoxycillin
IL131201A (en)	2005-06-19	Pharmaceutical formulations comprising amoxycillin and clavulanate
EP1189895B8 (fr)	2005-11-09	Derives de thiazol et d'oxazole et utilisation pharmaceutique de ceux-ci
AU5335698A (en)	1998-08-18	Pharmaceutical formulations with delayed drug release
AUPQ969800A0 (en)	2000-09-21	Pyrazolopyridine compound and pharmaceutical use thereof
AU2276801A (en)	2001-07-03	Extended release oral dosage composition
AU6089200A (en)	2001-02-05	Rapid immediate release oral dosage form
AU2001264313A1 (en)	2002-01-02	Pyrazolopyridine compounds and use thereof as drugs
AU4344000A (en)	2000-12-28	Drug releasing elastic band and method
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
AU1887401A (en)	2001-06-25	Medicinal composition
AU2002218502A1 (en)	2002-08-15	Lactam compounds and medicinal use thereof
AU2001227084A1 (en)	2001-08-07	N-arylhydrazide compounds and use thereof as drugs
AU5272399A (en)	2000-03-06	Non-porphyrin compound for use as a diagnosticum and/or pharmaceutical
AU1912501A (en)	2001-07-03	Water-soluble powders for oral solution and use thereof
AU1053501A (en)	2001-05-14	Polyazanaphthalene compound and medicinal use thereof
AUPQ462299A0 (en)	2000-01-13	Pyrazolopyridine compound and pharmaceutical use thereof
AU7887400A (en)	2001-04-30	A slow release pharmaceutical composition
AU2205401A (en)	2001-07-09	Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate
AU5483600A (en)	2001-01-02	Pharmaceutical materials and methods for their preparation and use
AU5974100A (en)	2001-01-31	6-carboxyphenyldihydropyridazinone derivatives and use thereof
IL123788A0 (en)	1998-10-30	(+)-O-demethyltramadol for use as a pain-killing drug for oral application
AU5343498A (en)	1998-08-07	Thiophene compounds and medicinal use thereof
AU6150400A (en)	2001-01-31	Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof